Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which chemo works best before a transplant? new trial aims to find out.

NCT ID NCT07025824

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 31 times

Summary

This study compares two chemotherapy drugs, treosulfan and melphalan, given before a stem cell transplant in people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). About 220 adults whose cancer is in remission or stable will take part. The goal is to see which drug leads to better survival and fewer side effects like graft-versus-host disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AML - ACUTE MYELOID LEUKEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Medizinische Fakultät der TU Dresden, Medizinische Klinik und Poliklinik I

    Dresden, Germany

    Contact

  • Universitätsklinikum Münster, Medizinische Klinik A, KMT-Zentrum

    Münster, Germany

    Contact

  • Universitätsklinikum Schleswig-Holstein, Campus Kiel

    Kiel, Germany

    Contact

  • Universitätsmedizin Halle (Saale)

    Halle, Germany

    Contact

Conditions

Explore the condition pages connected to this study.